📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes. (2014)

First Author: El-Jawhari JJ

Attributed to: Chromosomal translocation genes and their protein interactions in cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.molimm.2013.11.020

PubMed Identifier: 24365750

Publication URI: http://europepmc.org/abstract/MED/24365750

Type: Journal Article/Review

Volume: 58

Parent Publication: Molecular immunology

Issue: 2

ISSN: 0161-5890